Market Signal Briefing

Firelight believes the demand for DeFi security is at a critical inflection point, driven by the persistence of on-chain exploits.

The XRP staking platform Firelight is looking to introduce an on-chain exploit protection layer using staked XRP. This move comes amid a rise in decentralized finance (DeFi) exploits, with thefts in the first quarter of 2026 surpassing $137 million.

According to a press release sent to CryptoPotato, Firelight recently surpassed 50 million staked XRP on its protocol, recording a significant milestone on the Flare network.

Firelight Staked XRP Exceeds 50M Firelight attributed the growth in staked XRP to a wave of deposits from whales. Whale deposits have each exceeded 1 million XRP, and, collectively, the newly raised cap of an additional 40 million Flare XRP (FXRP).

CryptoPotato has reported that Flare is expanding XRP DeFi through its FAssets infrastructure. Users deposit XRP, mint FXRP on the fully overcollateralized bridge, and stake their FAssets into Firelight’s vault to receive staked XRP (stXRP). They can use stXRP across the Flare ecosystem.

Besides providing a liquid staking vault for XRP holders, Firelight also serves as an on-chain protection layer for DeFi assets. With rising demand for on-chain protection, the protocol is using staked XRP to provide an on-chain cover layer. This enables other chains to purchase protection against bad actors. The protection covers smart contract exploits, economic risk, oracle failures, and bridge vulnerabilities.

Introducing a Capital-Backed Protection Layer Firelight believes the demand for DeFi security is at a critical inflection point, as in the past week alone, a stablecoin protocol exploit due to a private key leak led to the loss of $23 million in unbacked tokens. The consistency of these exploits highlights the gap between DeFi growth and the maturity of risk infrastructure – Firelight aims to address this issue.

The first phase of the plan is to create a sustainable yield model for XRP stakers. Firelight has done this by enabling liquid staking with no slashing risk and audited vaults. The second phase, expected in Q2 2026, activates the full on-chain cover layer backed by the staked FXRP pool. This allows protocols to purchase the protection mechanism. Firelight is launching the protection layer in partnership with Sentora, an institutional DeFi intelligence platform formed through the merger of IntoTheBlock and Trident Digital.

You may also like: XRP Derivatives Surge on Binance as Long Liquidations Mount: What’s Next for Ripple? XRP’s Bearish Structure Holds – But Can Bulls Flip the Trend? Ripple (XRP) ETF Flows Weekly: The Good, the Bad, and What’s Next So far, Firelight has recorded significant demand for its staking vaults. Institutional and retail participants fully subscribed to the protocol’s inaugural deposit ceiling of 25 million FXRP within six hours of opening. They also surpassed the 50% fill mark a few hours after the protocol raised the cap to 65 million FXRP. This shows an eagerness to engage with a capital-backed on-chain protection mechanism.

Tags:

XRP (XRP) remained under pressure on Thursday UTC, trading in a narrow $1.35 to $1.40 band as the token struggled to regain momentum after a recent pullback. The price is now roughly 15% below a near-term peak around $1.60, with traders pointing to tight 'Bitcoin correlation', heavy 'whale distribution', and a broader reduction in leverage across crypto derivatives markets as key drags.

As of March 27 UTC, XRP’s price action has closely tracked Bitcoin (BTC), with market data indicating a correlation of roughly 0.80. While BTC has held a wide consolidation zone between $65,000 and $75,000, XRP has largely remained range-bound—suggesting that macro risk appetite and directional cues from BTC continue to dominate XRP’s short-term tape.

At the same time, supply dynamics have added friction to any attempted rebound. Around $6 billion worth of XRP has reportedly been released into the market by major holders, contributing to layered overhead resistance. Analysts cited $1.44, $1.58, and $1.76 as key levels where sell pressure has intensified, reinforcing a ceiling that has repeatedly capped rallies. Relative to an early-year high near $3.65, XRP is still down about 43%, underscoring how quickly liquidity conditions have tightened since the prior peak.

Derivatives positioning is also drawing attention. Open interest in XRP-linked products has risen since early March and is estimated around $946 million, signaling that speculative interest remains elevated despite the spot market’s lethargy. Binance has been highlighted as a key venue for the build-up, with open interest there rising roughly 14.8% over the period referenced by market trackers.

Notably, an estimated $314 million in short positions is concentrated between $1.375 and $1.405, a clustering that could act as fuel for abrupt moves if price pushes into liquidation territory. Negative funding rates—typically interpreted as traders paying to maintain short exposure—support the view that market bias has leaned defensive. In such setups, a rapid move higher can trigger a 'short squeeze', though sustained follow-through generally requires spot demand and improving risk sentiment rather than leverage alone.

Beyond price and positioning, Ripple has continued to push ecosystem and institutional narratives. The company recently introduced an AI-based security tool designed to strengthen the resilience of the XRP Ledger by identifying code vulnerabilities earlier and improving overall system reliability. Ripple is also expanding its footprint in Asia, joining the Monetary Authority of Singapore’s BLOOM initiative and establishing a partnership with Unlock, movements that signal a continued focus on the Asia-Pacific region as regulatory and enterprise adoption trends develop.

Regulatory catalysts could add another layer of volatility in the days ahead. A U.S. Securities and Exchange Commission decision deadline tied to the agency’s review of proposed XRP-related ETF filings is approaching, according to market watchers. Approval could bolster expectations of 'institutional inflows', while a delay or denial would likely amplify near-term uncertainty and trigger faster two-way moves—particularly given the concentration of leveraged positioning in a tight price corridor.

For now, XRP is holding above the $1.35 area, a level traders are treating as immediate support. Whether the token breaks down further or stages a relief bounce may hinge on Bitcoin’s next directional push, the persistence of large-holder selling, and how quickly derivatives leverage unwinds—or re-accelerates—into the SEC decision window.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Not every investor is interested in technology stocks. The sector can be prone to boom-and-bust cycles, and the enthusiasm for certain technologies (ahem, virtual reality) doesn't always translate into wins for investors.

But about 32% of the S&P 500 are tech stocks, and much of the gains the market makes come from this sector. That should be enough to convince you that holding at least a handful of tech stocks for the long term is a smart move. Here are three you should consider buying now.

Image source: Getty Images.

Broadcom's niche AI play Broadcom (AVGO 2.82%) designs application-specific integrated circuits (ASICs), which are specialized processors that are used in artificial intelligence (AI) data centers. While Nvidia (NVDA 2.13%) gets most of the attention for its AI chips -- and it should -- Broadcom fills a specific niche in the AI processor market, designed for targeted purposes like networking or running specific AI models.

The company will have an estimated 60% of the ASIC market by next year, according to CounterPoint Research, giving Broadcom a dominant position in this important AI market. And Broadcom is already benefiting from its lead, with AI revenue surging 106% in Q1 2026 to $8.4 billion.

More AI sales are on the way, too, with Broadcom's management saying that it expects AI revenue to be $10.7 billion in Q2 2026, representing a 143% increase from the year-ago quarter.

I'll confess that Broadcom's stock isn't exactly cheap. The company's shares have a trailing price-to-earnings (P/E) ratio of 60, compared to the tech sector average of about 37. But with Broadcom's niche in ASICs and demand for more AI data centers still high, this tech stock still looks like a good long-term tech play.

Today's Change

(

-2.82

%) $

-8.73

Current Price

$

300.68

Nvidia's dominance can't be overstated Nvidia may be the most obvious tech stock recommendation these days, but there are a few good reasons why it's worth investing in.

First, no other company comes close to Nvidia's dominance in AI processors. Nvidia has about 86% market share in AI data center chips, leading to massive sales and earnings growth for the company. In the recently reported fiscal year 2026, Nvidia's data center revenue jumped 68% to nearly $194 billion.

And just recently, CEO Jensen Huang said that Nvidia's AI processors could bring in $1 trillion in revenue through 2027. That huge demand is likely fueled by increasing AI data center spending by tech giants. Capital expenditures for Microsoft, Amazon, Meta Platforms, and Alphabet will reach $650 billion this year, with most of the spending going to artificial intelligence data centers.

Despite its impressive gains of 570% over the past three years -- and its potential to continue benefiting from AI -- Nvidia's shares have a P/E ratio of just 35, just under the tech sector's average. That means investors can buy Nvidia stock at a great price right now, even amid AI's rapid growth.

Today's Change

(

-2.13

%) $

-3.65

Current Price

$

167.59

Micron Technology looks like a bargain And last but not least is memory chip company Micron Technology (MU +0.59%). Like Nvidia and Broadcom, Micron is benefiting from the rapid increase in data center infrastructure spending.

Micron's revenue nearly tripled in the second quarter to nearly $23.9 billion as tech companies rushed to buy more memory for their data centers. The company's earnings per share skyrocketed, too, rising nearly 9X to $12.07 per share in the quarter.

To help keep pace with surging demand for memory, Micron will spend $200 billion to build new manufacturing facilities in the U.S. They'll come online over the next several years and should help the company ensure that Micron can take advantage of all the infrastructure spending currently underway.

Micron's P/E ratio of just 20 means investors are getting a very good deal on the top AI stock that will likely be an integral part of AI infrastructure for years to come.

While some parts of the technology sector will likely continue to be volatile, these tech stocks could be great additions to any portfolio if you're looking to ride the long-term benefits of artificial intelligence.

HomeStock IdeasIPO Analysis

SummaryWhile there were no traditional IPOs this past week, three blank check companies priced, and several sizable deals joined the pipeline.One IPO is currently scheduled in the week ahead, as markets remain trepid amid geopolitical volatility, although some smaller issuers may join the calendar throughout the week.Street research is expected for one company in the week ahead, and six lock-up periods will be expiring. bymuratdeniz/iStock via Getty Images

While there were no traditional IPOs this past week, three blank check companies priced, and several sizable deals joined the pipeline.

The week’s three blank check IPOs were led by Inflection Point Acquisition VI (IPFXU), which raised $220

7.43K Followers

HomeETFs and Funds AnalysisETF Analysis

SummarySchwab US Large-Cap Growth ETF is a popular large-cap growth ETF with a 0.04% expense ratio and $49 billion in assets under management. It's comprised of about 200 stocks selected based on six screens.Long-term results are terrific, and this article highlights how, with SCHG, you're actually getting excellent exposure to the quality factor. I'll present research showing why this quality is a great approach.Still, short-term risks exist. The Iran War will likely lead to higher energy prices, but beyond that, EPS surprises notably decelerated in Q4 2025 for SCHG's top ten holdings.I recognize this pattern, and I remind readers that even though consensus earnings growth estimates remain strong, Wall Street analysts were just as bullish (and wrong) for 2022.Overall, SCHG still earns a "hold" rating for its high-quality features, but the rating is under threat, and I expect a second straight quarter of weak EPS surprises will lead to a "sell." Supatman/iStock via Getty Images

Investment Thesis The Schwab US Large-Cap Growth ETF (SCHG) is down 10% YTD, but despite decelerating EPS surprises and higher energy costs, Wall Street analysts aren't budging. They're still predicting 23.36% aggregate EPS growth for SCHG, which is similar to

7.29K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of SCHD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

, /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Gemini Space Station, Inc. ("Gemini" or the "Company") (NasdaqGS: GEMI) of a class action securities lawsuit.

Kahn Swick & Foti CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Gemini Class A common stock pursuant and/or traceable to the Company's September 12, 2025 initial public offering ("IPO"), and/or Gemini securities between September 12, 2025 and February 17, 2026 (the "Class Period"). Follow the link below to get more information and be contacted by a member of our team:

https://www.ksfcounsel.com/cases/nasdaqgs-gemi/ 

Gemini investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-gemi/ to learn more.

CASE DETAILS: According to the Complaint, Gemini and certain of its executives are charged with failing to disclose material information in connection with its Offering Documents in Support of its IPO and/or during the Class Period, violating federal securities laws. 

The alleged false and misleading statements and/or omissions include, but are not limited to, that: (i) the Company  had overstated the viability of its core business as a crypto platform; (ii) the Company had overstated its commitment to and/or the viability of growing its business through expanding its international operations; (iii) accordingly, the Company's post-IPO financial and business prospects were overstated; (iv) all of the foregoing raised a non-speculative risk that the Company was poised for an expensive and disruptive restructuring; and (v) as a result, the Offering Documents and defendants' public statements throughout the class period were materially false and misleading at all relevant times.

The case is Methvin v. Gemini Space Station, Inc., et al., No. 26-cv-02261.

WHAT TO DO? If you invested in Gemini and suffered a loss during the relevant time frame, you have until May 18, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

SOURCE Kahn Swick & Foti, LLC

, /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NasdaqCM: SLNO) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of Soleno Therapeutics who were adversely affected by alleged securities fraud between March 26, 2025 and November 4, 2025. Follow the link below to get more information and be contacted by a member of our team:

Kahn Swick & Foti https://www.ksfcounsel.com/cases/nasdaqcm-slno/

Soleno investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqcm-slno/ to learn more.

CASE DETAILS: According to the Complaint, Soleno and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

The alleged false and misleading statements and/or omissions include, but are not limited to, that: (i) The Phase 3 clinical trial program for DCCR, the Company's only commercial product (for the treatment of hyperphagia in individuals afflicted with Prader-Willi syndrome or "PWS"), systematically minimized, mischaracterized, and/or failed to disclose substantial evidence of potential safety concerns associated with its administration, including indications of excessive fluid retention among clinical trial participants; (ii) as a result, the administration of DCCR to treat hyperphagia in individuals with PWS posed materially greater safety risks than disclosed by the Company; and (iii) consequently, DCCR had materially lower commercial viability and undisclosed risks related to the likelihood of significant and widespread adverse events after its commercial launch, including risks related to patient discontinuation rates, lower patient adoption, prescriber reluctance, adverse regulatory action, and potential reputational and legal fallout.

The case is City of Pontiac Police and Fire Retirement System v. Soleno Therapeutics, Inc., No. 26-cv-01979.

WHAT TO DO? If you invested in Soleno and suffered a loss during the relevant time frame, you have until May 5, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

SOURCE Kahn Swick & Foti, LLC

, /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NasdaqGS: RARE) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of Ultragenyx who were adversely affected by alleged securities fraud between August 3, 2023 and December 26, 2025. Follow the link below to get more information and be contacted by a member of our team:

Kahn Swick & Foti https://www.ksfcounsel.com/cases/nasdaqgs-rare/

Ultragenyx investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-rare/ to learn more.

CASE DETAILS: On December 26, 2025, the Company announced the "results from the Phase 3 Orbit and Cosmic studies for setrusumab (UX143) in Osteogenesis Imperfecta" disclosing that both its Phase III Orbit and Cosmic studies failed to demonstrate that setrusumab triggered a statistically significant reduction in annualized fracture rates for patients with osteogenesis imperfecta, and, as a result the Company "is evaluating its planned operations and will promptly define and implement significant expense reductions." On this news, the price of Ultragenyx's shares fell approximately 42%, from $34.19 per share on December 26, 2025 to $19.72 per share on December 29, 2025.

The case is Steven Bailey v. Ultragenyx Pharmaceutical Inc., et al., No. 26-cv-01097.

WHAT TO DO? If you invested in Ultragenyx and suffered a loss during the relevant time frame, you have until April 6, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

SOURCE Kahn Swick & Foti, LLC

New York, New York--(Newsfile Corp. - March 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BlackRock TCP Capital Corp. (NASDAQ: TCPC) between November 6, 2024, and January 23, 2026, inclusive (the "Class Period"), of the important April 6, 2026 lead plaintiff deadline.

SO WHAT: If you purchased BlackRock TCP securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the BlackRock TCP class action, go to https://rosenlegal.com/submit-form/?case_id=52921 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 6, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about BlackRock TCP's business, operations, and prospects. Specifically, defendants failed to disclose to investors that: (1) BlackRock TCP's investments were not being timely and/or appropriately valued; (2) BlackRock TCP's efforts at portfolio restructuring were not effectively resolving challenged credits or improving the quality of the portfolio; (3) as a result, BlackRock TCP's unrealized losses were understated; (4) as a result, BlackRock TCP's net asset value was overstated; and (5) as a result of the foregoing, defendants' positive statements about BlackRock TCP's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the BlackRock TCP class action, go to https://rosenlegal.com/submit-form/?case_id=52921 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/290329

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Shares of energy drink maker Celsius Holdings (CELH 4.41%) have taken a severe hit recently. Down a staggering 49% from its 52-week high of $66.74, the stock is currently trading at about $34 per share as of this writing.

Much of the recent pressure on the stock stems from news that wholesale giant Costco recently launched a private-label Kirkland Signature energy drink. The new product is priced significantly lower than Celsius, sparking fears of intensifying competition and prompting a sharp sell-off in the stock over the past week.

The Costco news highlights the competitive environment of the beverage space. But it's not the primary reason I'm cautious. The real issue keeping me on the sidelines today is valuation. Even after the stock has been nearly cut in half, its valuation may still reflect too much optimism.

Image source: Getty Images.

Ruthless competition Of course, the stock commands a premium valuation for a reason.

The company's fourth-quarter revenue came in at $722 million, up from $332.2 million in the year-ago quarter -- but with the help of some acquisitions. The company acquired Alani Nu on April 1 and the Rockstar Energy on Aug. 28.

Its acquisition of Alani Nu has been particularly successful. Management noted in the company's fourth-quarter earnings call that Alani's fourth-quarter net sales of $370 million represent 136% year-over-year growth on a pro forma basis.

However, growth in the beverage industry is rarely uncontested. The recent news of Costco introducing its own Kirkland Signature energy drink -- priced about 55% lower than Celsius products -- is a stark reminder of the challenges ahead. While Costco accounted for only about 11% of Celsius's total sales last year, Costco's move offers a reminder that competition in the energy drink space is intense.

If more retailers or other deep-pocketed competitors push aggressively into the category, Celsius could face pricing pressure, which, of course, would negatively impact its profit margins.

Indeed, we saw a glimpse of margin pressure in Q4, when the company's gross profit margin declined to 47.4% from 50.2% in the year-ago quarter. But this contraction was driven largely by integration and distribution costs associated with its recent acquisitions. Still, this is a key metric investors will be watching going forward.

Despite these clear competitive risks, the market is still valuing Celsius as if it can not only maintain its strong market positioning but also continue growing sales while protecting its margins. As of this writing, Celsius trades at a forward price-to-earnings ratio in the twenties -- not wildly expensive but certainly not cheap either.

The Costco news is ultimately just a symptom of a broader reality: competition in the beverage market is intense and -- sometimes -- even cutthroat.

Today's Change

(

-4.41

%) $

-1.57

Current Price

$

34.02

Celsius stock: time to buy? So, is Celsius stock a buy after falling 49% from its 52-week high? I don't think so.

The company has built a fantastic brand and is generating impressive sales growth. But at this valuation, the risk-reward trade-off simply isn't attractive enough to warrant buying shares today. The stock's current price requires the company not only to navigate an intensely competitive environment but also to continue growing at a robust rate while doing so.

There is always a possibility that Celsius will defy the odds and easily thrive in a more competitive environment, growing its earnings fast enough to make today's price look like a bargain in hindsight. But, for me, the stock looks too risky -- even at this price point.

NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PomDoctor Ltd. (NASDAQ: POM) between October 9, 2025 and December 11, 2025, inclusive (the “Class Period”), of the important April 7, 2026 lead plaintiff deadline.

SO WHAT: If you purchased PomDoctor securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the PomDoctor class action, go to https://rosenlegal.com/submit-form/?case_id=52621 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 7, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) PomDoctor was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; (3) PomDoctor’s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price; and (4) as a result of the foregoing, defendants’ positive statements about PomDoctor’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To join the PomDoctor class action, go to https://rosenlegal.com/submit-form/?case_id=52621 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

New York, New York--(Newsfile Corp. - March 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Paysafe Limited (NYSE: PSFE) between March 4, 2025 and November 12, 2025, inclusive (the "Class Period"), of the important April 7, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Paysafe securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Paysafe class action, go to https://rosenlegal.com/submit-form/?case_id=2745 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 7, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Paysafe's ecommerce business had significant exposure to a single high risk client; (2) as a result, Paysafe's credit loss reserves and/or write-offs were understated; (3) Paysafe had an undisclosed issue with higher risk Merchant Category Codes, making its client services difficult to bank; (4) the foregoing issues were likely to have a material negative impact on Paysafe's revenue growth and overall revenue mix; (5) as a result, Paysafe was unlikely to meet its own previously issued financial guidance for fiscal year 2025; and (6) as a result of the foregoing, defendants' positive statements about Paysafe's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Paysafe class action, go to https://rosenlegal.com/submit-form/?case_id=2745 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/290309

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

1.61K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

New York, New York--(Newsfile Corp. - March 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Coty Inc. (NYSE: COTY) between November 5, 2025 and February 4, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 22, 2026.

SO WHAT: If you purchased Coty common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Coty class action, go to https://rosenlegal.com/submit-form/?case_id=47083 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 22, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or concealed material adverse facts concerning the true state of Coty's slowing growth in the beauty market, notably, the Consumer Beauty market was underperforming, margins were compressed by increased marketing investments and there was slowing growth in its Prestige fragrance segment. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Coty class action, go to https://rosenlegal.com/submit-form/?case_id=47083 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/290333

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

New York, New York--(Newsfile Corp. - March 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Enphase Energy, Inc. (NASDAQ: ENPH) between April 22, 2025 and October 28, 2025, inclusive (the "Class Period"), of the important April 20, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Enphase securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Enphase class action, go to https://rosenlegal.com/submit-form/?case_id=25593 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 20, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Enphase overstated its ability to manage its channel inventory; (2) Enphase overstated its ability to mitigate effects arising from the termination of the Residential Clean Energy Credit; (3) accordingly, Enphase overstated its financial and operational prospects; and (4) as a result, Enphase's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Enphase class action, go to https://rosenlegal.com/submit-form/?case_id=25593 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/290334

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

CompaniesWASHINGTON, March 27 (Reuters) - A U.S. judge late Friday ordered ​Nexstar (NXST.O), opens new tab to temporarily keep ‌Tegna's assets separate pending a review of whether the ​broadcast station owner's $3.54 billion ​acquisition of its rival ⁠Tegna violates federal antitrust ​laws.

The companies quickly closed ​the deal after the Justice Department and Federal Communications Commision approved ​the deal on ​March 19.

Make sense of the latest ESG trends affecting companies and governments with the Reuters Sustainable Switch newsletter. Sign up here.

U.S. District Judge Troy Nunley ‌issued ⁠the order in response to a federal antitrust lawsuit filed by DirecTV, ​which argued ​it ⁠would irreparably drive up consumer costs, ​reduce local competition, shutter ​local ⁠newsrooms and increase both the frequency and duration ⁠of ​blackouts of ​key local sports teams.

Reporting by David ​Shepardson; Editing by William Mallard

Our Standards: The Thomson Reuters Trust Principles., opens new tab

SAN DIEGO, March 27, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Navan, Inc. (NASDAQ: NAVN) common stock pursuant and/or traceable to Navan’s offering documents issued in connection with Navan’s October 31, 2025 initial public offering (“IPO”), have until Friday, April 24, 2026 to seek appointment as lead plaintiff of the Navan class action lawsuit. Captioned McCown v. Navan, Inc., No. 26-cv-01550(N.D. Cal.), the Navan class action lawsuit charges Navan as well as certain of Navan’s top executives and directors and underwriters of the IPO with violations of the Securities Act of 1933.

If you suffered substantial losses and wish to serve as lead plaintiff of the Navan class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-navan-inc-class-action-lawsuit-navn.html

You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].

CASE ALLEGATIONS: Navan operates an AI-powered software platform to simplify the travel and expense experience, benefiting users, customers, and suppliers. According to the Navan class action lawsuit, on or about October 31, 2025, Navan conducted its IPO, issuing nearly 37 million shares to the public at the offering price of $25.00 per share.

The Navan class action lawsuit alleges that the IPO’s offering documents were materially false and/or misleading and/or omitted to state that Navan would increase its sales and marketing expenses by 39% just months after the IPO to sustain its revenue, Gross Booking Volume, and usage yield growth.

The Navan class action lawsuit further alleges that on December 15, 2025, Navan reported its earnings for the quarter ended October 31, 2025, and disclosed that it increased its sales and marketing expenses to nearly $95 million, a 39% increase from its $68.5 million sales and marketing expenses in the quarter ending July 31, 2025. On this news, the price of Navan stock fell nearly 12%, according to the Navan class action lawsuit.

The complaint alleges that by the commencement of the Navan class action lawsuit, the price of Navan stock has traded as low as $9.20 per share, a nearly 63% decline from the $25.00 per share IPO price.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Navan common stock pursuant and/or traceable to the IPO to seek appointment as lead plaintiff in the Navan class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Navan investor class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Navan shareholder class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Navan class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes. 
Services may be performed by attorneys in any of our offices. 

Contact:
        Robbins Geller Rudman & Dowd LLP
        J.C. Sanchez
        655 W. Broadway, Suite 1900, San Diego, CA 92101
        800-449-4900
        [email protected]

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Ethereum’s latest price structure is beginning to look like a pattern that has previously led to steep declines, and one analyst believes the signal is already in play.

A technical breakdown shared by Leshka.eth on X points to a SuperTrend reversal on the daily timeframe, which is a setup that has always led to heavy drawdowns for ETH. The structure is not new, but the way it is forming again has raised concern. If all goes according to the laid out structure, then the ETH price could crash to as low as $1,200.

The SuperTrend Indicator Has Flipped Again The SuperTrend indicator is a trend-following tool that plots dynamic support and resistance levels based on price volatility. This indicator has reversed bearish on Ethereum’s daily timeframe. According to chart analysis by Leshka.eth, this is the third time this setup has appeared in the current cycle, and the previous two instances ended in steep losses.

The first instance, which formed around the October and November 2025 period, saw Ethereum initially hold a support zone before breaking down. The collapse that followed measured approximately 45.03%, a selloff that wiped out a significant portion of the gains from earlier in the year. Notably, this selloff saw the ETH price fall from above $4,750 until it fell below $2,750.

Source: Chart from Leshka.eth on X The second setup came about in early 2026. Again, the ETH price appeared to find footing at a support level in early January, but that support eventually gave way during the second half of the month. This eventually led to a decline that looked like the first episode in magnitude, with the ETH price falling below $1,850 in the first week of February 2026.

That same transition is now taking place again. The SuperTrend has turned red, and this places Ethereum in a condition that has always favored continuation to the downside.

The Line In The Sand The outlook from this analysis places the important level to watch at $1,990. This is where the current SuperTrend reversal is forming, and it is the make-or-break zone for the near-term ETH outlook. The chart shows a dashed horizontal line as support around the $1,990 price level as the line in the sand that must not be broken. 

Price has already attempted to push higher into resistance around $2,300, as seen in the chart above but those moves have been rejected. According to Leshka.eth, if $1,900 breaks, then the next target is the $1,200 zone. 

The chart annotations point to drops of roughly 45% to 48% after similar setups, and applying that range to the current structure projects Ethereum’s next major zone around $1,200.

ETH price drops below $2,000 | Source: ETHUSDT on Tradingview.com Featured image from iStock, chart from Tradingview.com

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Sign Up for Our Newsletter! For updates and exclusive offers enter your email.

Scott Matherson is a leading crypto writer at Bitcoinist, who possesses a sharp analytical mind and a deep understanding of the digital currency landscape. Scott has earned a reputation for delivering thought-provoking and well-researched articles that resonate with both newcomers and seasoned crypto enthusiasts. Outside of his writing, Scott is passionate about promoting crypto literacy and often works to educate the public on the potential of blockchain.

Solana [SOL] bulls have faced a tough situation in recent weeks. Bitcoin’s [BTC] rally to $76K by 17 March saw Solana prices break out of a range that it had been within since the first week of February.

This range breakout naturally meant momentum and volume were on the bulls’ side, convincing traders that more gains were possible. In hindsight, the failure to defend the $89.9-range highs was the first sign of bearishness.

Source: SOL/USDT on TradingView The 1-day chart showed that the range formation was only a consolidation after a sharp downtrend. During this consolidation, the OBV has trended higher to signal accumulation.

At the same time, the RSI remained above neutral-50 to sustain the idea that bullish momentum could last. In the broader picture, any rally would have struggled to overcome the $105-$120 supply zone.

The most recent one was unable even to break the $100-level. With the price back at the mid-range level, what should traders expect next?

Bounce or a further breakdown ahead for SOL? Source: SOL/USDT on TradingView The range extended from $76.6 to $89.9, with the mid-point at $83.3. At the time of writing, Solana was trading slightly below the mid-range level. The technical indicators were also firmly bearish.

The DMI highlighted a strong downtrend in progress on the 4-hour timeframe, with the RSI falling towards the oversold zone. The OBV was also about to make new local lows to capture the selling volume over the past ten days.

It is possible that Solana would bounce from the mid-range support, but traders have to be careful. In a range, the range extremes are the most desirable zones for a trade entry targeting the opposing extreme.

At the mid-range, and given the recent market sentiment, it is difficult to justify entering long positions.

Source: CoinGlass The Bitcoin long squeeze to the $66.5k-level, at the time of writing, had pulled SOL into the magnetic zone at $83. To the south, another pocket of long liquidations lay at $79, just below the $80.2 lows made on 08 March.

Traders will want to see the current liquidity hunt bounce back above $83-$85 before they can have some faith in a short-term rally. This move can go as high as $94-$98 in search of short liquidations.

Final Summary Bitcoin’s sell-offs over the past two weeks affected SOL prices. In the next 24-48 hours, a drop to $79 is possible, but a short-term bounce would become possible if SOL climbs back above $83-$85.

TL;DR:

Explosive Growth: BitGo closed fiscal year 2025 with revenue of $16.15 billion, representing a 424% increase over the previous period. Treasury Loss: Despite record billing, the company recorded a net loss of $50 million in Q4 due to the devaluation of its Bitcoin reserves. Market Impact: Following the report’s publication, BTGO shares fell 8.17% in after-hours trading, settling at $9.10 per share. BitGo Holdings presented its first earnings report as a public company. The document reveals a scenario of contrast marked by massive revenues and hidden hits from market volatility. The firm, which debuted on the New York Stock Exchange in January, faces the challenge of balancing its operational expansion with the fluctuations of its digital assets.

BitGo $BTGO reported 4Q and FY25 results – our first as a public company – this afternoon.

We posted total revenue growth of 440% and 424% in the fourth quarter and full year 2025, respectively. Growth in both periods was driven by higher digital asset trading activity,… pic.twitter.com/26WnXLSXE7

— BitGo (@BitGo) March 26, 2026 The company’s adjusted EBITDA showed resilience, increasing 904% to $32.4 million. However, the gross margin on digital asset sales remained at a narrow 0.21%, underscoring the company’s reliance on high transaction volumes to sustain profitability against assets on platform that fell to $81.6 billion.

Despite the number of clients doubling to 5,322, market sentiment was affected by the swing in net income. In the same quarter of the previous year, BitGo enjoyed a net profit of $129.4 million, a figure that has now transformed into red ink due to unrealized losses on Bitcoin.

Regulatory expansion and new BitGo services On the other hand, the company has achieved significant milestones in its institutional structure. For example, in December 2025, it obtained conditional approval from the OCC to operate as a federally chartered digital asset trust bank, strengthening its competitive position.

Additionally, its new Stablecoin-as-a-Service offering contributed $66.7 million, demonstrating that diversification into higher-margin services is a key strategy. This segment already exceeded $5 billion in assets under management by early 2026.

BitGo is navigating a stage of accelerated growth overshadowed by direct exposure to treasury volatility. The market now watches cautiously to see if its robust regulatory infrastructure can offset asset valuation losses in the coming quarters.

Investor sentiment in the crypto market sits at its lowest point in months — and the biggest Bitcoin holders are treating it like a buying window.

Retail Sellers, Whale Buyers While everyday investors have been stepping back, wallets holding between 10 and 10,000 Bitcoin added roughly 61,568 coins over the past 30 days, according to data from market analytics firm Santiment.

That 0.45% increase in holdings came even as geopolitical tensions flared and broader financial markets turned choppy. At the same time, the smallest wallets — those holding under 0.01 BTC — also added coins, picking up around 213 Bitcoin, a 0.42% rise. The two groups moved in the same direction, but for different reasons, analysts say.

🐳📈 Despite dipping to $68.1K today, Bitcoin’s key stakeholders are accumulating. Whales and sharks with 10-10K $BTC have accumulated 61,568 BTC (+0.45%) in the past month, which is a promising sign of an eventual breakout from this range.

🤑 Besides the current macroeconomic… pic.twitter.com/YDbRYNYH85

— Santiment (@santimentfeed) March 26, 2026

Source: Santiment Dominick John, an analyst at Zeus Research, said that large holders are quietly stacking during flat-price periods, not reacting to daily headlines. Small wallet holders, he said, are driven by something else entirely — fear of missing out when prices tick upward.

“Small wallets are chasing the momentum,” John said, adding that if retail buying overheats, a brief sell-off before the next accumulation wave is possible.

A Pattern Analysts Have Seen Before Santiment analysts pointed to a longer historical pattern: when large wallets accumulate while smaller holders are selling, it has often preceded the start of a sustained price rise.

The firm called the current behavior a “promising sign” that a breakout from the months-long trading range could be ahead — and that the direction of that breakout is more likely to be up than down.

BTCUSD trading at $66,521 on the 24-hour chart: TradingView Bitcoin exchange outflows have also been steady throughout March, data shows. Coins leaving exchanges typically signal holders are moving assets into cold storage, a sign they plan to hold rather than sell in the short term.

Not every major holder has been buying, though. On March 19, two Bitcoin whales moved tens of millions of dollars worth of coins onto exchanges — a move that often precedes a sale. That day, Bitcoin prices dropped as attacks on Gulf oil and gas infrastructure pushed energy prices higher and rattled markets tied to the Iran conflict.

Source: Alernative.me Extreme Fear Grips The Market The Crypto Fear & Greed Index recorded a score of 10 on Thursday and 13 on Friday. Both readings fall firmly in “extreme fear” territory. The entire month of February and the week prior both averaged the same. A score of zero represents maximum fear; 100 represents peak greed.

That kind of prolonged fear reading is unusual. It reflects a market where uncertainty has settled in — not as a spike, but as a sustained mood. Middle East tensions have been a key driver. US and Israeli strikes against Iran in February triggered a wave of retaliations across the region, and the conflict has continued to weigh on global markets since.

Featured image from EG Healthcare, chart from TradingView

TL;DR:

An unknown entity accumulated over $35 million in XRP in less than an hour, using a high-precision algorithmic execution strategy. The operation was fragmented into 156 identical purchases of 10,000 XRP each, strategically distributed across Coinbase, Kraken, and Bitstamp exchanges. Despite the strong buying pressure, the XRP price remained stable at $1.33, recording a modest 1.4% gain for the day. Mystery whales continue to shake the crypto market. This Friday, a mystery whale made a massive XRP purchase, executing a series of orders across major exchanges. The technical maneuver, detected by market analysts, allowed the buyer to conceal a significant capital entry without drastically altering immediate liquidity.

Due to this action, buying volume exploded around 11:00 UTC, reversing a flat trend in the CVD (Cumulative Volume Delta). The activity was led by Coinbase with $23.4 million, while Kraken and Bitstamp served as secondary nodes to distribute the buying pressure.

Algorithmic strategy and market behavior Analyst Dom (@traderview2) highlighted that using bots to fractionate an order of such magnitude is uncommon in daily trading. This tactic prevented the price from exploding before the total accumulation of the asset was complete.

Some entity just rapidly accumulated $35M+ $XRP in less than an hour and it seems like they needed it quick

It happened mainly on Coinbase, but Bitstamp and Kraken followed along

– 156 identical buys of 10,000 XRP each
– Fired like clockwork every 18.5 seconds for 48 minutes
-… pic.twitter.com/hlm48eUlga

— Dom (@traderview2) March 27, 2026 Despite this sudden capital inflow, XRP’s price action remained relatively measured. The token is currently trading around $1.33, representing a modest 1.4% gain in the last 24 hours of trading.

On the other hand, the asset shows notable strength in its parity against Bitcoin, recording a 2.3% increase against the market leader. This signifies that while the dollar price remains stable, XRP is gaining ground within the crypto market.

The coordinated execution across multiple platforms demonstrates a high level of institutional sophistication. The market remains alert to whether this movement precedes a relevant announcement or a larger appreciation phase for XRP.

The average public miner spent $79,995 to produce one bitcoin last quarter. Bitcoin is trading at $70,000. The math doesn't work, so the industry is pivoting to AI, taking on $70 billion in contracts, and liquidating bitcoin treasuries to finance the shift. Mar 28, 2026, 2:30 a.m.

The bitcoin mining industry is undergoing the most fundamental transformation in its history, and the clearest sign isn't the hashrate or the difficulty adjustments. It's the balance sheets.

CoinShares' Q1 2026 mining report, published this week, reveals that the weighted average cash cost to produce one bitcoin among publicly listed miners rose to approximately $79,995 in Q4 2025.

Bitcoin has traded in the $68,000 to $70,000 band, with a CoinDesk report last week estimating losses of $19,000 per BTC mined.

These numbers aren't sustainable, and the industry knows it. The response has been a wholesale pivot toward artificial intelligence infrastructure that is reshaping what these companies actually are.

Over $70 billion in cumulative AI and high-performance computing contracts have now been announced across the public mining sector, according to the CoinShares report. CoreWeave's expanded deal with Core Scientific alone is worth $10.2 billion over 12 years. TeraWulf has $12.8 billion in contracted HPC revenue. Hut 8 signed a $7 billion, 15-year lease for AI infrastructure at its River Bend campus. Cipher Digital has a multi-billion-dollar agreement with Google-backed Fluidstack.

Listed miners could derive as much as 70% of their revenue from AI by the end of 2026, up from roughly 30% today. Core Scientific's AI colocation revenue already accounts for 39% of its total. TeraWulf is at 27%. IREN is at 9% and scaling rapidly with up to 200 megawatts of liquid-cooled GPU capacity under construction.

That means these mining companies are increasingly becoming data center operators that happen to still mine bitcoin on the side.

The economics explain why. According to CoinShares, the cost differential between bitcoin mining infrastructure at roughly $700,000 to $1 million per megawatt and AI infrastructure at $8 million to $15 million per megawatt is wide, but AI offers structurally higher and more stable returns.

Hash price, the metric that determines miner revenue per unit of computing power, hit an all-time post-halving low of roughly $28 to $30 per petahash per day in early March.

At those levels, miners running mid-generation hardware need access to electricity below $0.05 per kilowatt-hour to remain cash-profitable. Meanwhile, AI infrastructure contracts promise margins above 85% with multi-year revenue visibility.

How the financials workThe transition is being financed in two ways, and both are visible in the data, the report explained.

First, debt. The sector's aggregate leverage has fundamentally changed. IREN now carries $3.7 billion in convertible notes across five series. TeraWulf has $5.7 billion in total debt, split between convertible notes and senior secured notes at its compute subsidiary.

Cipher Digital issued $1.7 billion in senior secured notes in November, causing its quarterly interest expense to surge from $3.2 million for the first nine months to $33.4 million in Q4 alone. These are not mining-scale debt loads. These are infrastructure-scale bets that the AI revenue will materialize fast enough to service the obligations.

Second, bitcoin sales. Publicly listed miners have collectively reduced their BTC treasuries by over 15,000 BTC from peak levels. Core Scientific sold roughly 1,900 BTC worth $175 million in January and is planning to liquidate substantially all remaining holdings in Q1 2026. Bitdeer reduced its treasury to zero in February. Riot Platforms sold 1,818 BTC worth $162 million in December.

Even Marathon, the largest public holder at 53,822 BTC, quietly expanded its policy in its March 10-K filing to authorize sales from its entire balance sheet reserve, partly driven by pressure on its $350 million bitcoin-backed credit facility where the loan-to-value ratio climbed to 87% as prices fell toward $68,000.

The miners that are selling bitcoin to fund AI buildouts are the same companies whose mining operations secure the bitcoin network. That creates a tension at the heart of the transition. When mining is unprofitable and AI is lucrative, the rational economic decision is to reallocate capital away from mining. But if enough miners do that, the network's security budget shrinks.

The hashrate data already reflects this. The network peaked at approximately 1,160 exahashes per second in early October 2025 and has since declined to roughly 920 EH/s, with three consecutive negative difficulty adjustments, the first such streak since July 2022.

The valuation market has already priced the bifurcation. Miners with secured HPC contracts now trade at 12.3 times next-twelve-month sales. Pure-play miners trade at 5.9 times. The market is paying more than double for the AI exposure, which reinforces the incentive to pivot further.

The geographic picture is shifting alongside the economics, meanwhile. The United States, China, and Russia now control roughly 68% of global hashrate. The U.S. gained about 2 percentage points of market share in Q4 alone.

But emerging markets are entering the picture. Paraguay and Ethiopia have joined the global top 10 mining countries, driven by HIVE's 300-megawatt operation in Paraguay and Bitdeer's 40-megawatt facility in Ethiopia.

Hashrate forecasts and estimatesCoinShares forecasts the network hashrate will reach 1.8 zetahashes by the end of 2026 and 2 zetahashes by end of March 2027, one month later than previously predicted.

But that forecast depends on bitcoin recovering to $100,000 by year-end. If prices stay below $80,000, CoinShares expects hash price to continue falling and the hashrate to decline further as more miners exit.

A sustained move below $70,000 could trigger larger capitulation that, paradoxically, benefits survivors through lower difficulty.

Next-generation hardware offers a potential lifeline. Bitmain's S23 series and Bitdeer's proprietary SEALMINER A3, both operating below 10 joules per terahash, are expected at scale through the first half of 2026. These machines would roughly halve the energy cost per bitcoin compared to current mid-generation fleets. But deploying them requires capital that many miners are directing toward AI instead.

The bitcoin mining industry entered this cycle as a group of companies that secured the network and accumulated bitcoin. It is exiting as a group of companies that build AI data centers and sell bitcoin to fund them.

Whether that's a temporary response to unfavorable economics or a permanent structural shift depends on one variable: the price of bitcoin. If it returns to $100,000, mining margins recover and the AI pivot slows. If it stays at $70,000 or below, the transition accelerates and the mining sector as it existed for the past decade continues to disappear into something else entirely.

More For You

As stablecoins evolve into core financial infrastructure, North America leads. This report maps the regulation, market shifts, and players driving adoption.

Why it matters:

Stablecoins are entering their third phase of evolution - the institutionalization era - becoming increasingly embedded into core financial infrastructure. As institutions prioritize transparency and compliance, regulated issuers like USDC, RLUSD, and PYUSD are steadily gaining share with RLUSD surpassing $1B in market cap within its first year. North America, leading in regulatory frameworks and institutional distribution, is at the center of it all.

More For You

The bank priced its proposed spot bitcoin fund at 14 basis points, making it the lowest fund on the market, if approved.

What to know:

Morgan Stanley plans to launch a spot bitcoin ETF priced at 14 basis points, undercutting current low-cost rivals and potentially igniting a new fee war.Because spot bitcoin ETFs offer nearly identical exposure, Morgan Stanley's lower fee could prompt advisors to shift client assets from higher-cost funds.If approved, the...

Wall Street analysts commonly offer one-year price projections on stocks they cover. While any individual analyst's forecast for where a stock will be a year from now could be way off in either direction, looking at the average of all those price targets ought to give investors a good idea of where the market in the aggregate thinks the stock could be headed. It also demonstrates whether the community is generally bullish or bearish on a stock, which is why that price target data can be a great tool for those in search of promising investment opportunities.

Right now, Wall Street analysts on average view Nvidia (NVDA 2.13%), Nebius (NBIS 4.76%), and Microsoft (MSFT 2.44%) as having massive upsides. 

Image source: Getty Images.

Nvidia With Nvidia already the largest company in the world by market cap, you may be inclined to assume that its upside would be fairly limited, but that's not the case. Its sales are still growing at a rapid pace, and demand for its AI computing units has proven insatiable. During its fiscal 2026 fourth quarter, which ended Jan. 25, Nvidia's revenue rose 73% year over year, and management guided for 77% growth in fiscal 2027's first quarter. Few companies ever deliver growth at those paces, yet Nvidia is still doing it despite its already-massive revenues.

Today's Change

(

-2.13

%) $

-3.65

Current Price

$

167.59

The average 12-month price target on the stock is about $270. Considering that Nvidia is trading at $175 right now, that would be a rise of about 57%. That's why I think it's a no-brainer buy right now.

Nebius Nebius is actually a company that Nvidia is currently invested in -- a vote of confidence from the giant chipmaker. The AI data center operator has a market cap just below $30 billion -- less than 1% of Nvidia's value -- but it's doing big things as a company. Nebius has a deal with Nvidia that gives it access to the chipmaker's new products despite a tight market for its hardware. The ability to supply servers powered by Nvidia's GPUs has made it a go-to partner for several AI hyperscalers that need more capacity, including Microsoft and Meta Platforms (META 3.91%).

Nebius is growing rapidly: Management expects its annual run rate to increase from $1.25 billion at the end of 2025 to between $7 billion and $9 billion by the end of 2026.

Today's Change

(

-4.76

%) $

-5.05

Current Price

$

100.92

The current average stock price target on Nebius is $167, about 47% higher than today's levels. That would be a solid gain for a one-year investment, and I think it showcases that Nebius is worth an investment.

Microsoft Microsoft has gotten off to a rough start in 2026. It's down about 24% year to date. That decline is a bit of a head-scratcher, as the company delivered excellent results for its most recent quarter.

In its fiscal 2026 Q2, which ended Dec. 31, revenue rose 17% year over year while earnings per share climbed 60%, in part thanks to a rise in the value of its OpenAI investment. Its non-GAAP earnings, which stripped out the effect of that gain, rose 24%, showcasing strength across the board. Despite this, Microsoft's stock continued to decline and now sits at a price-to-earnings ratio the company has seldom seen in the past decade.

MSFT PE Ratio data by YCharts.

Wall Street analysts are similarly questioning Microsoft's decline. Their average price target on the stock is $595, 55% above today's level. I think a P/E ratio of about 24 offers about as great an entry point for Microsoft's stock as investors can ask for. Take advantage of this sale price to load up on it while you still can.

Keithen Drury has positions in Meta Platforms, Microsoft, Nebius Group, and Nvidia. The Motley Fool has positions in and recommends Meta Platforms, Microsoft, and Nvidia. The Motley Fool has a disclosure policy.

This biotech specializing in endocrine therapies reported a notable insider sale as it advances clinical-stage drug candidates.

Key PointsA director of Crinetics Pharmaceuticals reported that he sold 5,000 shares of the company for a transaction value of approximately $180,761 on March 12, 2026.

The sale represented 23.47% of Coelho’s direct common stock holdings, reducing direct ownership from 21,300 to 16,300 shares.

All shares sold were directly held; no indirect or derivative holdings were involved in this transaction.

Rogerio Vivaldi Coelho, a director of Crinetics Pharmaceuticals (CRNX 7.27%), reported the sale of 5,000 shares of common stock in open-market transactions on March 12, 2026, according to a SEC Form 4 filing.

Transaction summaryMetricValueShares sold (direct)5,000Transaction value~$181KPost-transaction common shares (direct)16,300Post-transaction value (direct ownership)~$595KTransaction value based on SEC Form 4 weighted average purchase price ($36.15).

Key questionsHow does the size of this sale compare to Coelho’s past trade history?
This is the only open-market sale disclosed by Coelho for Crinetics Pharmaceuticals.What was the proportion of direct ownership affected by this transaction?
The sale accounted for 23.47% of Coelho’s direct common stock holdings, reducing the position from 21,300 to 16,300 shares, with all remaining shares held directly and no indirect or derivative exposure reported in the Form 4.Was this transaction part of a routine liquidity plan?
Yes, the filing specifies the sale was executed automatically under a Rule 10b5-1 trading plan adopted on Dec. 11, 2025, indicating a pre-scheduled, non-discretionary approach to portfolio management.What valuation context surrounds the transaction?
Shares were sold at a weighted average price of around $36.15 per share, closely aligned with both the March 12, 2026, market close of $36.51 and the latest price of $37.28 as of March 17, 2026, offering liquidity without a substantial discount or premium to prevailing market levels.Company overviewMetricValuePrice (as of market close 3/12/26)$36.15Market capitalization$3.97 billionRevenue (TTM)$7.7 millionNet income (TTM)-$465.32 millionCompany snapshotCrinetics Pharmaceuticals develops oral therapeutics targeting rare endocrine diseases and endocrine-related tumors, with key clinical-stage candidates including Paltusotine, CRN04777, and CRN04894.The firm operates a research-driven model focused on advancing proprietary compounds through clinical trials and regulatory approval, with future revenues expected from product commercialization and licensing.It targets endocrinologists, specialty physicians, and healthcare providers treating rare endocrine disorders and neuroendocrine tumors.Crinetics Pharmaceuticals, Inc. is a clinical-stage biotechnology company specializing in the development of oral therapies for rare endocrine disorders. The company leverages its expertise in receptor pharmacology and drug discovery to advance a pipeline of novel small-molecule therapeutics. With a focus on unmet medical needs in the endocrine space, Crinetics aims to establish a competitive position through differentiated, first-in-class product candidates.

What this transaction means for investorsIt seems that the recent sale is more a strategic liquidity move than a signal of confidence in the business, especially since it was carried out under a Rule 10b5-1 plan and marks the director’s first public open-market sale of this stock specifically. Plus, with shares down about 4% over the past year, the timing doesn’t suggest any aggressive profit-taking.

At Crinetics Pharmaceuticals, the focus is now shifting from development to early commercialization. The company saw $7.7 million in revenue for 2025, largely fueled by the launch of its lead drug, Palsonify, which generated $5.4 million in its first quarter on the market. This launch also gained momentum, with over 200 enrollment forms and more than 125 prescribing physicians by the end of the year. However, R&D spending remains high, exceeding $330 million annually as Crinetics pushes forward multiple late-stage programs, including critical trials for atumelnant.

On a positive note, the pipeline is expanding internationally. Crinetics recently submitted a marketing application for Palsonify in Brazil, supported by data from 18 clinical trials, including two successful Phase 3 studies. With around $1.4 billion in cash post-offering, the company is well-positioned for growth, and that’s what investors should pay attention to more than insider sales like this one.

Read Next

About the Author

Jonathan Ponciano is a contributing stock market analyst at The Motley Fool. He has nearly a decade of experience as a financial journalist, most recently as an editor and senior reporter at Forbes focused on markets, technology, and entrepreneurship. Jonathan has also written for Investopedia and the Los Angeles Business Journal. He holds a dual B.A. in Business Journalism and Economics from the University of North Carolina at Chapel Hill and an M.B.A. from Columbia Business School. A North Carolina native now based in New York City, Jonathan has also lived in Mexico City and Los Angeles.